Insights

Strategic partnership Covaris recently partnered with Hamilton Robotics to co-market the truXTRAC FFPE SMART Solution, signaling a channel-ready opportunity to expand automation-enabled sample prep offerings into integrated workflows with robotics partners.

Expansion of offerings The launch of the truCOLLECT Solution in 2026 indicates Covaris is expanding its portfolio in pre-analytical sample collection and prep, creating cross-sell opportunities to customers seeking end-to-end sample handling solutions.

Acquisition backing As a PerkinElmer company acquired in 2023 and backed by New Mountain Capital, Covaris benefits from strong financial stability and broader distribution, enhancing credibility for enterprise-level deployments and larger contract opportunities.

Security and reliability A recent data breach in 2024 highlights the importance of robust data security and compliance in collaborating with life-science customers, presenting a sales angle around safeguarding sample data and instrument software ecosystems.

Multiomics focus Covaris’ leadership in Adaptive Focused Acoustics technology across multiomics research and clinical applications points to high value use cases with academic and biopharma customers pursuing reproducible, high-quality data—ideal for upsell into high-throughput or regulated workflows.

Covaris Tech Stack

Covaris uses 8 technology products and services including Microsoft SharePoint, Magento, JSON-LD, and more. Explore Covaris's tech stack below.

  • Microsoft SharePoint
    Content Management System
  • Magento
    E-commerce
  • JSON-LD
    Javascript Frameworks
  • Lightbox
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • .NET
    Programming Languages
  • Piwik PRO Core
    Web Analytics
  • FlexSlider
    Widgets

Media & News

Covaris's Email Address Formats

Covaris uses at least 2 format(s):
Covaris Email FormatsExamplePercentage
FLast@covaris.comJDoe@covaris.com
99%
FMiddleLast@covaris.comJMichaelDoe@covaris.com
1%
FLast@covarisinc.comJDoe@covarisinc.com
80%
Last@covarisinc.comDoe@covarisinc.com
19%
FirstL@covarisinc.comJohnD@covarisinc.com
1%

Frequently Asked Questions

What is Covaris's official website and social media links?

Minus sign iconPlus sign icon
Covaris's official website is covaris.com and has social profiles on LinkedInCrunchbase.

What is Covaris's SIC code NAICS code?

Minus sign iconPlus sign icon
Covaris's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Covaris have currently?

Minus sign iconPlus sign icon
As of July 2026, Covaris has approximately 144 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: J. L.Sales Director Europe: O. S.Director Of Sales Marketing And Support (fas): S. M.. Explore Covaris's employee directory with LeadIQ.

What industry does Covaris belong to?

Minus sign iconPlus sign icon
Covaris operates in the Biotechnology Research industry.

What technology does Covaris use?

Minus sign iconPlus sign icon
Covaris's tech stack includes Microsoft SharePointMagentoJSON-LDLightboxjQuery.NETPiwik PRO CoreFlexSlider.

What is Covaris's email format?

Minus sign iconPlus sign icon
Covaris's email format typically follows the pattern of FLast@covaris.com. Find more Covaris email formats with LeadIQ.

How much funding has Covaris raised to date?

Minus sign iconPlus sign icon
As of July 2026, Covaris has raised $882K in funding. The last funding round occurred on Mar 04, 2016 for $732K.
Covaris logo

Covaris

Biotechnology ResearchMassachusetts, United States51-200 Employees

Covaris is a mid-sized biotechnology company based in Woburn, Massachusetts, focused on sample preparation for multiomics research and clinical applications. Since its acquisition by PerkinElmer in 2023, it operates within the PerkinElmer portfolio and offers a range of instruments, consumables, reagents, and kits used in pre-analytical sample processing. The company emphasizes accuracy and reproducibility to help researchers generate high-quality data and support assay development. Its customer base includes academic laboratories as well as global biopharma organizations. In April 2026, Covaris introduced the truCOLLECT Solution, reflecting ongoing product development in its field.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $882K

    Covaris has raised a total of $882K of funding over 2 rounds. Their latest funding round was raised on Mar 04, 2016 in the amount of $732Kas a grant.

  • $50M$100M

    Covaris's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $882K

    Covaris has raised a total of $882K of funding over 2 rounds. Their latest funding round was raised on Mar 04, 2016 in the amount of $732Kas a grant.

  • $50M$100M

    Covaris's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.